Manufacturing

Gisli Herjolfsson, M.Eng., is co-founder and CEO of Controlant, gisli@controlant.com.

Articles

For pharmaceutical manufacturers and their contract partners, blockchain and the Internet of Things promise to enable return on investment, not only by preventing counterfeiting and verifying returns but by enabling real-time condition monitoring and automating supply contracts.

Blockchain and IoT: Determining ROI in the Pharma Supply Chain

The 120-day pilot program was set up to help reduce the availability of unapproved opioids illegally offered for sale online.

FDA and NTIA Launch Pilot Program to Stop Unapproved Opioid Sales

Dominic Hyde is vice-president of Pelican BioThermal’s CrÄdo on Demand. 

The future will bring changes for temperature-controlled container rental companies.

What’s Next in Air Transportation for Clinical Trial Logistics

Agnes Shanley is senior editor of Pharmaceutical Technology.

Previous investments set a foundation for later efficiency improvements. 

2019 Investments Centered around Cell and Gene Therapies

The VIA Capsule from Cytiva is a liquid nitrogen-free cryogenic shipment system designed to transport cell therapies.

Cryogenic Capsule for Shipment of Cellular Therapies

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

The global COVID-19 pandemic has highlighted the need for the pharmaceutical industry to strengthen its supply chain.

Securing the Supply Chain

Dr. Reddy Gottipolu is SVP Healthcare at One Network Enterprises, provider of an AI-enabled business network platform that enables all trading partners to manage, optimize and automate complex business processes in real time.

A network-based supply chain approach has the potential to improve resilience and performance.

New Resilience: How COVID-19 Delivered the Ultimate Stress Test for Pharma Supply Chains

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

US manufacturers focus on preparing capacity while vaccines and treatments for COVID-19 are being developed and tested.

Preparing to Meet Manufacturing Needs During a Pandemic

Evonik opened a new facility for GMP manufacturing of bioresorbable polymers and excipients for pharmaceutical and medical applications in Birmingham, AL.

Evonik Commissions US Facility for Bioresorbable Polymers and adds CMO Services

Quartic.ai and Bright Path Laboratories have agreed to develop an artificial intelligence (AI)-powered continuous manufacturing platform for APIs and other small-molecule drugs using Bright Path Labs’ continuous bioreactor and the Quartic.ai smart manufacturing technology.